Skip to main content

Modern PCI

See the vessel with HD IVUS

Get inside knowledge of coronary arteries with state-of-the art imaging

No more flying blind outside the arterial walls. Unlike coronary angiography, intravascular ultrasound (IVUS) gives you inside knowledge of coronary arteries. Assess plaque type and severity with PCI guidance tools that eliminate guesswork. The result: clearer treatment decisions, fewer future complications, and the best long-term outcomes.


ACC imaging recommendations

Intravascular imaging is recommended as a necessary complement to traditional angiography and as such, should be utilized as a best practice while performing PCI. Authors suggest that ideally, both OCT and IVUS should be available at facilities for their different applications but if only one technology can be available, HD IVUS should be preferred:

“Given the limited reimbursement for IVI, this may not be economically feasible for every program. In general, we believe if only 1 technology can be employed, IVUS (especially using the higher-definition IVUS systems) is the more flexible of the options and is the one that can be utilized in almost all clinical scenarios.”

AVVIGO™+ Multi-Modality Guidance System

  • Next-generation PCI guidance system designed to provide a high-quality imaging and physiology experience, all in one easy-to-use platform
  • Machine learning software to automate key procedural steps
  • Faster IVUS image acquisition with automatic pullback
  • Quickly locate regions of pressure change during a pressure wire pullback with PhysioMap™
AVVIGO™ Guidance System II

IVUS imaging

  • Superior HD IVUS image quality enables user to clearly see disease
  • Flexible catheter in 2 sizes (5F and 6F) to assist in more PCI procedures
  • Use during procedure planning, stent placement, and post- procedure
OPTICROSS

Physiology / FFR

  • A reliable and highly deliverable Physiology wire that can help to determine whether to treat
  • Favorable clinical outcomes compared to angiography
  • Optimal workhorse performance to diagnose and treat
COMET II

Our PCI guidance products portfolio

Clinical data: The importance of IVUS and physiology-guided procedures

Image-Guided PCI Tops Angiography​

The recent RENOVATE-COMPLEX-PCI study provides evidence in favor of using intravascular imaging-guided PCI to address complex coronary artery lesions. At the 3-year follow-up, intravascular imaging-guided PCI demonstrated a reduced risk of target vessel failure when compared to angiography-guided PCI.¹

Read about the RENOVATE-COMPLEX-PCI Study

1. Lee, Joo Myung, et al. “Intravascular Imaging–Guided or Angiography-Guided Complex PCI.” New England Journal of Medicine, vol. 388, no. 18, 5 Mar. 2023, pp. 1668–1679, https://doi.org/10.1056/nejmoa2216607

SYNTAX II offers significant improvement in long-term outcomes:

The SYNTAX II1 clinical trial is a landmark study proving that IVUS guidance of coronary arteries and Modern PCI techniques give statistically significant improvement in long-term outcomes, leading to better treatment decisions and a reduction in rates of revascularization, peri-procedural MI, and acute ST.

Read about the SYNTAX II study.

1. The SYNTAX II Trial studied the SYNERGY Bioabsorbable Polymer Stent in patients with either CTO or three vessel disease. The SYNTAX I trial studied the TAXUS Express2 drug eluting stent in patients with either Left Main or three vessel disease. Banning, Adrian, MBBS, MD. Clinical outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 5-year results of the SYNTAX II study. ESC Congress 2021.

IVUS guidance lowers MACE post-procedure:

Clinical studies reveal that IVUS-guidance led to the use of larger stents, more post-dilation, additional stenting, or higher pressures in patients, resulting in lower rates of ST, MI, and TLR. Using IVUS vs coronary angiography alone leads to a statistically significant difference in MACE three years post-procedure.

Read the IVUS clinical studies.

Measuring FFR reduces long-term MI likelihood:

The FAME I & II trials show that using FFR led to statistically significant reduction of cardiac death or MI at 5 years compared to coronary angiography. Measuring FFR can also help identify those for whom the treatment is most appropriate, and lower costs.

Read the FFR studies, including FAME I and II.

Training and education

Expand your PCI guidance skill set with our live and virtual training

woman on a tablet

IVUS 123 Essentials

  • Step-by-step guide to simplify IVUS workflow
  • Assess pre-stent workflow, lesion size, plaque type, and vessel size
  • Post-stent validation

IVUS Series on EDUCARE

  • Online, on-demand imaging courses
  • Interactive learning exercises
  • Real-life case studies
  • Lessons from clinical leaders

View all training for Coronary Interventions


Connect with us

Talk to a rep

Fill out a short form and one of our sales representatives will be in touch with you.

Receive updates

Stay informed on the latest advancements surrounding our products and solutions.